Covid-19 roundup: India halts AstraZeneca vaccine exports as in-country cases rise — report
As the number of positive Covid-19 cases rises in the country, India is temporarily holding on exports of the AstraZeneca vaccine, Reuters reported.
The vaccine is being produced by the Serum Institute of India, which is the world’s largest vaccine manufacturer. There have been no vaccine exports from India since last Thursday.
That will limit the supply of vaccines to the World Health Organization’s COVAX vaccine-sharing facility, which has received 17.7 million of the 60.5 million doses the country has exported, Reuters said. COVAX has a deal to buy 1.1 billion doses of the AstraZeneca and Novavax shots.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
